These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38121226)

  • 21. Gout therapeutics: new drugs for an old disease.
    Burns CM; Wortmann RL
    Lancet; 2011 Jan; 377(9760):165-77. PubMed ID: 20719377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality in Patients With Gout Treated With Allopurinol: A Systematic Review and Meta-Analysis.
    Hay CA; Prior JA; Belcher J; Mallen CD; Roddy E
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):1049-1054. PubMed ID: 32286732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of nephrolithiasis in patients with primary gout: a cross-sectional study using helical computed tomography.
    Shimizu T; Hori H
    J Rheumatol; 2009 Sep; 36(9):1958-62. PubMed ID: 19605673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
    Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
    Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in management of gout.
    Suresh E; Das P
    QJM; 2012 May; 105(5):407-17. PubMed ID: 22198943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inquiry is fatal to certainty-is the ultrasonography double contour sign specific for uric acid-induced arthritis?
    Adinolfi A; Picerno V; Di Sabatino V; Bertoldi I; Galeazzi M; Frediani B; Filippou G
    Arthritis Rheum; 2013 Jul; 65(7):1952. PubMed ID: 23553056
    [No Abstract]   [Full Text] [Related]  

  • 27. Carpal tunnel syndrome due to tophaceous gout.
    Rich JT; Bush DC; Lincoski CJ; Harrington TM
    Orthopedics; 2004 Aug; 27(8):862-3. PubMed ID: 15369009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Educational inequalities in all-cause and cause-specific mortality among people with gout: a register-based matched cohort study in southern Sweden.
    Kiadaliri A; Moreno-Betancur M; Turkiewicz A; Englund M
    Int J Equity Health; 2019 Oct; 18(1):164. PubMed ID: 31660978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational therapy for hyperuricaemia.
    Monteagudo FS; Meyers OL
    S Afr Med J; 1986 Mar; 69(6):338. PubMed ID: 3961614
    [No Abstract]   [Full Text] [Related]  

  • 30. Cause-Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study.
    Helget LN; England BR; Roul P; Sayles H; Petro AD; Neogi T; O'Dell JR; Mikuls TR
    Arthritis Care Res (Hoboken); 2023 Apr; 75(4):808-816. PubMed ID: 35294114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medial canthal tophus.
    Jordan DR; Belliveau MJ; Brownstein S; McEachren T; Kyrollos M
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):403-4. PubMed ID: 18806664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes.
    Wei J; Choi HK; Dalbeth N; Li X; Li C; Zeng C; Lei G; Zhang Y
    JAMA Netw Open; 2023 Aug; 6(8):e2330885. PubMed ID: 37624597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal gout tophus: a very rare cause of radiculopathy.
    Hasturk AE; Basmaci M; Canbay S; Vural C; Erten F
    Eur Spine J; 2012 Jun; 21 Suppl 4(Suppl 4):S400-3. PubMed ID: 21594750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial.
    Saag KG; Becker MA; White WB; Whelton A; Borer JS; Gorelick PB; Hunt B; Castillo M; Gunawardhana L;
    Arthritis Rheumatol; 2022 Sep; 74(9):1593-1601. PubMed ID: 35536764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inquiry Concerning Cold Water in Gout.
    Norman W
    Lond Med Phys J; 1816 Mar; 35(205):203. PubMed ID: 30493873
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in understanding and managing gout.
    Igel TF; Krasnokutsky S; Pillinger MH
    F1000Res; 2017; 6():247. PubMed ID: 28357052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gout--current diagnosis and treatment.
    Tausche AK; Jansen TL; Schröder HE; Bornstein SR; Aringer M; Müller-Ladner U
    Dtsch Arztebl Int; 2009 Aug; 106(34-35):549-55. PubMed ID: 19795010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.
    Vargas-Santos AB; Neogi T; da Rocha Castelar-Pinheiro G; Kapetanovic MC; Turkiewicz A
    Arthritis Rheumatol; 2019 Nov; 71(11):1935-1942. PubMed ID: 31169353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopurinol Dose Escalation and Mortality Among Patients With Gout: A National Propensity-Matched Cohort Study.
    Coburn BW; Michaud K; Bergman DA; Mikuls TR
    Arthritis Rheumatol; 2018 Aug; 70(8):1298-1307. PubMed ID: 29513934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.